For due diligence or investment opportunities

We have worked closely with investment banks to examine CMC packages, usually from small biotechs, as part of due diligence activities and recommend, via detailed written reports, whether the investment opportunity is sound, whether there are potential showstoppers, and identify other reasons why the investment should or should not be pursued.